Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Oct 10, 2011; 2(10): 339-343
Published online Oct 10, 2011. doi: 10.5306/wjco.v2.i10.339
Published online Oct 10, 2011. doi: 10.5306/wjco.v2.i10.339
Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy
Kenji Ina, Ryuichi Furuta, Department of Medical Oncology, Nagoya Memorial Hospital, Nagoya 468-8520, Japan
Takae Kataoka, Satoshi Kayukawa, Takashi Yoshida, Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya 468-8520, Japan
Takaya Miwa, Yoshitaka Yamamura, Yuuki Takeuchi, Department of Surgery, Nagoya Memorial Hospital, Nagoya 468-8520, Japan
Author contributions: Ina K, Furuta R and Kataoka T designed the research; Ina K, Furuta R, Miwa T, Yamamura Y and Takeuchi Y performed the research; Ina K, Kayukawa S and Yoshida T analyzed the data; Ina K wrote the paper; all authors drafted the article and gave final approval of the version to be published.
Correspondence to: Kenji Ina, Dr., Department of Medical Oncology, Nagoya Memorial Hospital, 4-305 Hirabari, Tenpaku-ku, Nagoya 468-8520, Japan. kina@hospy.or.jp
Telephone: +81-52-8041111 Fax: +81-52-8038830
Received: May 25, 2011
Revised: August 1, 2011
Accepted: August 8, 2011
Published online: October 10, 2011
Revised: August 1, 2011
Accepted: August 8, 2011
Published online: October 10, 2011
Core Tip